chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I screened patient, with mother in the room, mother verbally confirmed all questions and patients DOB, when confirming patient was here for second dose of Pfizer (5-11yrs old) mom verbally stated it was patients second dose, mother had forgotten the vaccination card, before vaccinating patient, I checked the patients chart for the date in previous dose had met the 21 days,  the first dose I seen was administered on 03/15/2022,  I failed to see that under that the series number it was reading as a second dose, it was mislabeled in the chart, the patients card was written with this date as his first and proceeded to administer the vaccine thought to be a second dose on  4/6/2022 at 3:45pm. he had received his first true dose  on 1/04/2022. The error was not caught until the patient had left  after the 15 min observation time was up with no observable signs of allergic reaction. The error was caught when  entering the vaccine into the patient's chart, the series was reading as third. I called mother after the flow of vaccine clinic was over at 4:52pm to explain the situation, mother was informed of the error and was given information on possible side effects as well as offered her to speak to a provider if she had any further concerns or questions about the incident, mother refused, mother stated she was aware this was a third time receiving the vaccine as provider had verbally told her they would be restarting the series as they had missed the appointment for the appointment for the second dose. Mother confirmed the patient had no compromised immune system that would make him eligible for the 3rd dose. Mother was informed that it wasn?t necessary  to restart the series. Mother had no concerns when I spoke to her on the phone, stated she would monitor patient for any symptoms.
Starting Saturday 4/3 at 3pm I started having fatigue, nausea, fever, chills, aches, vomiting and diarrhea. All symptoms lasted until Sunday 4/4 around 5am. Fever, nausea, fatigue, and aches lasted until Monday 4/5 around 9am.
Facial Droop Right Side of Face Diagnosed on 10/26/2015 with Bell's Palsy Right side of face.
Fever; chills; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (chills) and MYALGIA (muscle aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced PYREXIA (Fever), CHILLS (chills) and MYALGIA (muscle aches). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. On 14-Mar-2021, MYALGIA (muscle aches) had resolved. At the time of the report, PYREXIA (Fever) and CHILLS (chills) had not resolved. Not Provided          No relevant concomitant medications were reported.   Reporter did not allow further contact
Information has been received from a nurse concerning a 24 month old patient who on 19-SEP-2011 was vaccinated with a dose of VARIVAX (Merck) (lot# unspecified). The nurse mentioned that on 24-MAY-2012 the patient had outbreaks of varicella. The patient had contacted the office. At the time of the report, the patient's status was unknown. This was one of the several reports from the same source. Follow-up information was received from a registered nurse who stated that the 2 year old female patient with no pre-existing allergies no birth defects and no medical conditions and no illness at the time of vaccination who on 19-SEP-2011, was vaccinated with the first dose of VARIVAX (Merck) (lot# not provided). The nurse reported that the patient went to the clinic with a healing rash described as "patient had a fever of 103, the following day she broke out into rash (vesicles and pustules), rash began on genitals then arms and legs. The rash were scabs for past 3 days. The patient had a daycare with other children with same rash". The patient was diagnosed with varicella. The patient did not have any testing done. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Information has been received from a physician concerning a 12 year old female patient with no pertinent medical history, who "about 2 weeks ago", on approximately 20-AUG-2009 was vaccinated intramuscularly with the first dose of GARDASIL, 0.5ml. The doctor stated that "about 2 weeks ago", on approximately 20-AUG-2009, the patient experienced dizziness, syncope and her systolic blood pressure dropped 20 points. It was reported that "about 2 weeks ago", on approximately 20-AUG-2009, the patient recovered from dizziness, syncope and systolic blood pressure dropped 20 points. The patient sought unspecified medical attention. Additional information has been requested.
extremely tired/extremely tired; extremely exhausted; foggy headed; sore arm; fever; chilling; Very achy; This is a spontaneous report from a contactable consumer (patient herself). A 70-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9265), via an unspecified route of administration, administered in right arm on 09Feb2021 10:00 (age at vaccination: 70 years) as Dose 2, SINGLE DOSE for covid-19 immunisation. The patient's medical history included low thyroid, high cholesterol and allergies. The patient previously took Ceclor and penicillin experienced drug hypersensitivity. The patient historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9261) administered in right arm on 19Jan2021 10:00.  On 09Feb2021 12:00, the patient with in few hours was extremely exhausted, foggy headed, sore arm, fever, chilling and was very achy.  The patient had to sleep most of the day. On 11Feb2021, the patient was extremely tired/extremely tired  On an unknown date (reported as overnight), the patient's pyrexia was 99-101. On 11Feb2021 (reported as Thursday), brain fog lifted and felt able to think again. Also most soreness gone. on 12Feb2021 (reported as today) feel almost back to normal, was very tired. The patient did not have any other vaccine in four weeks. The patient did not receive any treatment for the adverse event. The patient did not have covid prior vaccination nor was tested for covid post vaccination. The outcome of the event fatigue was not recovered, pain was unknown and all the other events were recovered on an unknown date in 2021.  Follow-up attempts completed. No further information expected.
been sick off and on every since; Cough wont go away; no energy; feel like crap; Initial information received on 08-Jan-2023 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves an unknown age and gender patient who reported after receiving influenza vaccine, had been sick off and on ever since, cough won't go away, no energy and feel like crap.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect influenza vaccine produced by unknown manufacturer (strength, form, expiry date, lot number: not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed non-serious events of been sick off and on ever since (illness), cough won't go away (cough), no energy (asthenia) and feel like crap (feeling abnormal) (unknown latency) following the administration of influenza vaccine.  Action taken with influenza vaccine was not applicable.  It was not reported if the patient received a corrective treatment for the events (been sick off and on ever since, Cough won't go away, no energy, feel like crap).  At time of reporting, the outcome was Not Recovered / Not Resolved for the event cough won't go away and was Unknown for all the rest events (been sick off and on ever since, no energy and feel like crap).
developed chills; achiness; headache; crawling sensation in her throat; This is a spontaneous report from a contactable nurse (patient). A 62-year-old female patient received the first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 19May2021 (received at the age of 62-years-old) as DOSE 1, SINGLE for COVID-19 immunization.  Medical history included immune compromised from an unspecified date and ongoing. Concomitant medications were not reported. The patient experienced chills, achiness, headache, crawling sensation in her throat on May2021. The patient received her first Pfizer Covid vaccine dose on 19May2021. After which she developed chills, achiness, and a headache. She states that later that same day she had "a crawling sensation" in her throat. She was apprehensive about getting the second dose and was advised by an HCP to take Benadryl before the second dose of the vaccine on 08Jun2021. Therapeutic measures were taken as a result the adverse events. Outcome of the events was unknown.   Information on batch number has been requested.
Pt received vaccination on 11/17/06 and had localized reaction to left thigh with redness, swelling, warmth.
Left upper forearm erythema, warm, tender to touch non-edematous. Sx began day after injection.
PATIENT FULLY VACCINATED AND TESTED POSITIVE FOR COVID 9/5/2021 AND ADMITTED TO HOSPITAL 9/5/2021
A 53-year-old female patient with unknown medical history and no reported concomitant medications had received second dose of IMOVAX intramuscularly on 10 August 2012 (batch number unknown and anatomical site of administration was not reported). The patient had previously received first dose of IMOVAX on 07 August 2012 and also received IMOGAM on 07 August 2012 (batch number unknown, route and site of administration not reported). The patient was bitten by a stray cat on 04 August 2012 which was destroyed before testing. On 10 August 2012, the patient had an anxiety attack which started 12 hours after the dose an had severe racing heart and flushing and called it an anxiety attack. Laboratory investigation and corrective treatment was not reported. The event anxiety attack was lasted for 36 hours however the overall outcome was reported as not recovered. Follow up information received from a non-healthcare professional 02 January 2013; the patient had received other 3 doses of IMOVAX (lot number: unknown, route and anatomical site of administration were not reported) on unspecified dates. No further information was available at the time of this report. Documents held by send: None.
Fever; Chills; Nausea; Headache; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26May2021 at 16:00 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26May2021, the patient experienced fever, chills, nausea, headache, body aches. Therapeutic measures were taken as a result of event and included treatment with Ibuprofen and fluids. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. On 31May2021, the patient underwent nasal swab and the result was negative. The clinical outcome of the events fever, chills, nausea, headache, body aches was recovered on an unknown date of 2021.   No follow-up attempts are needed; information about lot number cannot be obtained. No further information is expected.
Decreased appetite, non-stop crying, elevated temp (100.9 degrees F) per Dr. (primary provider) likely from DTaP. No local reaction.
Fever 102, Fatigue, Vomited x1,Ill x 3days.
Report of pain at injection site as well as swelling. Also developed a rash from the elbow to the shoulder. The rash was itchy last night, but is no longer itchy.
fever 104.4 had febrile sz 48-60hr s/p immun;no rx @ ER;fever persisted x 2 more days;inc WBC w/lt shift;rx w/ATB 30MAY98;small mass @ lt immunization site (ventral legs)
left arm (where vaccine was administered) was swollen; left arm (where vaccine was administered) was red; left arm (where vaccine was administered) was itching, it was bigger and more itchy; left arm (where vaccine was administered) was itching with a small rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (left arm (where vaccine was administered) was swollen) and VACCINATION SITE ERYTHEMA (left arm (where vaccine was administered) was red) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE SWELLING (left arm (where vaccine was administered) was swollen) (seriousness criterion intervention required), VACCINATION SITE ERYTHEMA (left arm (where vaccine was administered) was red) (seriousness criterion intervention required), VACCINATION SITE PRURITUS (left arm (where vaccine was administered) was itching, it was bigger and more itchy) and VACCINATION SITE RASH (left arm (where vaccine was administered) was itching with a small rash). The patient was treated with Physical therapy (ice) for Vaccination site swelling; Physical therapy (ice) for Vaccination site erythema; Physical therapy (ice) for Vaccination site pruritus and Physical therapy (ice) for Vaccination site rash. At the time of the report, VACCINATION SITE SWELLING (left arm (where vaccine was administered) was swollen), VACCINATION SITE ERYTHEMA (left arm (where vaccine was administered) was red), VACCINATION SITE PRURITUS (left arm (where vaccine was administered) was itching, it was bigger and more itchy) and VACCINATION SITE RASH (left arm (where vaccine was administered) was itching with a small rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Treatment reported was antibiotics (for one week) for adverse events.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
I experienced two adverse events after receiving the vaccine. My first adverse event was that I had a 10 day cycle at which I lost over 40 ml of blood per hour. I was put on birth control to regulate the bleeding. My second adverse event was that my doctor told me to get a mammogram, and the day I was going to schedule the appointment, I found a lump on my breast. I went to the doctor on 06/25 and he thought I had mrsa. It turned out to be a bacterial infection ,that was not mrsa, in my breast. I was put on antibiotics and he drained it.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. During 2013, the patient was inoculated with ZOSTAVAX by a physician as recommended for routine adult health maintenance for the prevention of shingles (lot #, dose and route not provided). The vaccine did not prevent shingles as intended.  On or about 30-MAY-2016, the patient was treated by the same physician and was diagnosed with herpes zoster, or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Sudden onset of neuropathy symptoms approximately 24 hours after the vaccine, which persisted for 3 weeks
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients receiving expired doses) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031H21A) for COVID-19 vaccination. No Medical History information was reported. On 05-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients receiving expired doses). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients receiving expired doses) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication information was provided. Patient received the second booster dose. No treatment medication were provided.
Swelling of the face, first right and then left side; feels like needles; Red all over; Tingling; Broke up in hives; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SWELLING FACE (Swelling of the face, first right and then left side), URTICARIA (Broke up in hives), PAIN (feels like needles), ERYTHEMA (Red all over) and PARAESTHESIA (Tingling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced URTICARIA (Broke up in hives), ERYTHEMA (Red all over) and PARAESTHESIA (Tingling). On an unknown date, the patient experienced SWELLING FACE (Swelling of the face, first right and then left side) and PAIN (feels like needles). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at a dose of 2 tablets, some times 3.. At the time of the report, SWELLING FACE (Swelling of the face, first right and then left side), URTICARIA (Broke up in hives), PAIN (feels like needles), ERYTHEMA (Red all over) and PARAESTHESIA (Tingling) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Antibiotic, Another Antibiotic (didn't specify), Benadryl 2 tablets, some times 3, Steroids. No concomitant medication information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow up information was received and contact number was updated.
Extreme dizziness; This is a spontaneous report from a non-contactable consumer, the patient. A 48-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 12May2021 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021, two days after second shot, the patient experienced extreme dizziness. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event extreme dizziness was recovered on 14May2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Parents here for 4 month shots - states infant had severe reaction after 1st set of immunizations at 2 months old (given on 04/14/2005).  Had inconsolable crying for period lasting up to an hours time for 3-4 days.  102 degrees fever for 3-4 days despite Tylenol, every 4 hours, also vomiting, moaning, arching of back with crying.
Stevens-Johnson like reaction: multiple blister forming lesions that turned into bruise-like appearance, very pruritic, started w/ mild flu like symptoms. Lesions primarily on trunk, neck, buttocks/genitals, and corners of the mouth.
Bioject delivery of vaccine  large warm red swelling lasted 72 hours hoarseness, scratchy throat, dry non productive cough, runny nose (clear) , post nasal discharge, difficulty breathing & sleeping. Slight fever, body aches, cough, sneezing, sinusitus continues at 96 hours +
shortly after participant received her vaccination she developed a red rash on upper chest and forearms.  She also had swelling of her lips.
This is a spontaneous report from a contactable consumer, reporting for himself. A 85-year-old male patient of an unspecified ethnicity started to receive PREVNAR 13, via an unspecified route of administration on an unspecified date in 2016 at single dose for immunisation. The patient medical history and concomitant medications were not reported. The patient experienced headaches and mucus, that he feels are sinus related on an unspecified date with outcome of unknown. The patient underwent lab tests and procedures which included computerised tomogram: grossly clear sinuses.
11/13/2020 began running a fever that lasted until 11/16/2020.  One 11/17/2020 a splotchy rash developed that last until 11/20/20.  On 11/23/2020 developed a fever that lasted for 24 hours and developed a different rash of red dots appearing like polka dots.
3rd dose 06Jan2023; This case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 18-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMZA759A, expiry date 30th November 2023) for prophylaxis.   Previously administered products included Menveo (1st dose received on 15th December 2011) and Menveo (2nd dose received on 15th December 2020).   On 6th January 2023, the patient received the 3rd dose of Menveo. On 6th January 2023, unknown after receiving Menveo, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.   Additional Information: GSK receipt date: 09-JAN-2023 Reporter's comment: The licensed practical nurse (LPN) enquired about any harmful side effects and what to look for if they had inadvertently administered a third dose of Menveo (2 vial) to a patient. The reporter did not consent to follow-up. Additional supportive information: The patient received 3rd dose of Menveo, which led to extra dose administered.